178 filings
Page 5 of 9
8-K
vddn1f5dg5k38
27 Nov 19
Aravive Announces Proposed Public Offering of Common Stock
4:15pm
8-K
kaf0m9p
20 Nov 19
Other Events
7:05am
8-K
eiytjjezy
8 Nov 19
CORRECTION – Aravive Reports Third Quarter 2019 Financial Results and Provides Recent Corporate Updates
2:33pm
8-K
9lls g0w6cr1
7 Nov 19
Aravive Reports Third Quarter 2019 Financial Results and Provides Recent Corporate Updates
4:10pm
8-K
u4b2kd
3 Oct 19
Other Events
7:15am
8-K
kp1ef
27 Sep 19
Other Events
10:15am
8-K
c46je
13 Sep 19
Departure of Directors or Certain Officers
4:05pm
8-K
3gpw1kqbbxi3v9p l3
12 Aug 19
Other Events
7:05am
8-K
04po69ef
8 Aug 19
Aravive Announces Executive Management Transition Plan
5:06pm
8-K
jjz2j7 tit
7 Aug 19
Aravive Reports Second Quarter 2019 Financial Results and Provides Recent Corporate Updates
4:10pm
8-K
bi6t09zn675qf80ed8
31 Jul 19
Aravive Reports Preliminary Results ofAVB-500 from the First Cohort of the Phase 1b/Phase 2 Recurrent Platinum Resistant Ovarian Cancer Trial
7:15am
8-K
e7qsm9hxx1x dja7f12l
11 Jul 19
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
7:32am
8-K
wodqfz049cf22pi8
8 Jul 19
Other Events
7:16am
8-K
nockgw9t
31 May 19
Termination of a Material Definitive Agreement
4:16pm
8-K
tu9j59ixkixop3yf 1p4
8 May 19
Aravive Reports First Quarter 2019 Financial Results and Provides Recent Corporate Updates
4:15pm
8-K
nhem0j3wdigoog vf
11 Apr 19
Departure of Directors or Certain Officers
4:29pm
8-K
5sxyegb4w9o jiz4c1a4
26 Mar 19
Entry into a Material Definitive Agreement
6:07am
8-K
nz9qbarkfry
7 Mar 19
Results of Operations and Financial Condition
4:16pm
8-K
hnqadxbqe
6 Mar 19
Departure of Directors or Certain Officers
6:05am
8-K
ady5tek
12 Feb 19
Departure of Directors or Certain Officers
4:20pm